Mayo Clinic is among the most active breast cancer research facilities in the world. Mayo Clinic researchers conduct many clinical trials to find drug combinations and treatments that result in improved outcomes for people who have inflammatory breast cancer.
Cancer research is conducted in coordination with the Mayo Clinic Cancer Center. The Mayo Clinic Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center — recognition for an institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.
Women's Cancer Program
The Women's Cancer Program at Mayo Clinic brings together doctors and researchers in breast and gynecologic surgery, medical and radiation oncology, medical genetics, pathology, and other specialties to develop new therapies for women's cancers. As part of the Mayo Clinic Cancer Center, the Women's Cancer Program offers access to potential new therapies through clinical trials. The Women's Cancer Program also provides emotional and social support classes, a resource center and educational programs for women and their families.
See a list of publications by Mayo Clinic authors on inflammatory breast cancer on PubMed, a service of the National Library of Medicine.
March 12, 2015
- Breast cancer. Fort Washington, Pa.: National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed Feb. 18, 2015.
- Inflammatory breast cancer: Questions and answers. National Cancer Institute. http://www.cancer.gov/cancertopics/factsheet/Sites-Types/IBC. Accessed Feb. 19, 2015.
- Dawood S, et al. International expert panel on inflammatory breast cancer: Consensus statement for standardized diagnosis and treatment. Annals of Oncology. 2011;22:15.